SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities107/05/2017
4Statement of changes in beneficial ownership of securities107/05/2017
CT ORDERConfidential treatment order106/27/2017
4Statement of changes in beneficial ownership of securities106/23/2017
4Statement of changes in beneficial ownership of securities106/09/2017
8-KCurrent report pursuant to Section 13 or 15(d)306/01/2017
4Statement of changes in beneficial ownership of securities105/30/2017
4Statement of changes in beneficial ownership of securities105/26/2017
4Statement of changes in beneficial ownership of securities105/26/2017
4Statement of changes in beneficial ownership of securities105/26/2017
4Statement of changes in beneficial ownership of securities105/26/2017
4Statement of changes in beneficial ownership of securities105/26/2017
8-KCurrent report pursuant to Section 13 or 15(d)305/26/2017
8-KCurrent report pursuant to Section 13 or 15(d)205/23/2017
4Statement of changes in beneficial ownership of securities105/15/2017
101112131415161718192021222324